Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348400 · ClinicalTrials.gov registry record · Phase 4
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00348400 is a Phase 4 study that has completed, run by Innovative Medical.
The verdict
NCT00348400, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
Interventions
- DRUG Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348400
The ClinicalTrials.gov registry entry for NCT00348400 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost is the first listed.
NCT00348400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00348400 about?
NCT00348400 is a clinical study titled "Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost". Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
What is the current status of trial NCT00348400?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00348400?
The interventions under investigation include: Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost (DRUG).
Who is sponsoring clinical trial NCT00348400?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.